Aristotle University Of Thessaloniki (AUTH)
Μελέτη βιομορίων σε λεμφοκύτταρα ασθενών με αυτοάνοσα ρευματικά νοσήματα
Abstract
dc:descriptionCD26 (dipeptidyl peptidase IV, DPPIV) is a multifunctional cell surface protein which is involved in T lymphocyte activation and proliferation probably through interactions with adenosine deaminase and CD45. Rheumatoid Arthritis and Systemic Lupus Erythematosus are connective tissue disorders. Despite their different pathophysiology, the role of T lymphocytes is essential in both diseases. The aim of the thesis was to investigate the involvement of CD26, CD45 and the adenosine deaminase, in the pathophysiology of Rheumatoid Arthritis and Systemic Lupus Erythematosus. The expression of CD26, CD45RA and CD45RO in CD4 and CD8 lymphocytes was studied by flow cytometry. The enzymatic activity of total ADA and its isoenzymes ADA1 and ADA2 was determined by spectrophotometric method. Thirty-three patients with RA, 10 patients with SLE and 15 with osteoarthritis (control group) were enrolled in the study. Rheumatoid arthritis patients were subdivided in four groups according to the disease activity index, DAS28CRP (no activity, low, median and high activity), in four groups according to their treatment (no treatment, corticosteroids, disease modifying antirheumatic drugs and biological agents) and in two groups according to rheumatoid factor (seronegative, seropositive). The statistical analysis was conducted with SPSS 18 statistical package and non-parametric methods were used. CD3CD4 and CD4CD26 T lymphocytes were increased in RA patients compared to OA patients whereas CD3CD8 and CD8CD26 were higher in SLE patients. In the subgroup of RA patients in biologic agents, an increase in CD3CD8, CD8CD26, CD8CD45RA and CD8CD45RO lymphocytes was observed compared with the other treatment subgroups. Seronegative RA patients had elevated CD8CD26 lymphocytes compared to seropositive. This is consistent with the protective role of CD8 T lymphocytes in RA. The reduced enzymatic activity of ADA1 and increase of ADA2/tADA percentage determined in this study in RA and SLE patient’s sera indicates that ADA2 enzymatic activity is increased in RA and SEL patients. The enzymatic activity of ADA is mainly due to isoenzyme ADA2 which increases in inflammation. Finally, there was a statistically important positive correlation between CD4CD26, and CD4CD45RA and CD4CD45RO lymphocytes in all three main groups and between CD8CD26 and CD8CD45RA in RA and SEL patients. That indicates the co-expression of CD26 and CD45 in T lymphocytes. CD26 regulates the phosphatase activity of CD45 influencing T cell activation through TCR/CD3 complex. These results confirm the involvement of CD26, CD45 and ADA in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus. The predominance of CD4 subpopulations (CD3CD4, CD4CD26) in RA and of CD8 (CD3CD8, CD8CD26) in SLE is in accordance with the different pathophysiology of the two autoimmune diseases. The CD4 lymphocytes dominate in RA synovium having a central role in the disease pathogenesis whereas CD8 lymphocytes are increasing in active lupus and they are implicated in the release of autoantigens. CD26 is expressed on activated T lymphocytes and as a costimulatory molecule; it induces T cell activation and proliferation. Further studies will be conducted to investigate the interactions between CD26 and CD45 and between CD26 and ADA in autoimmune rheumatic diseases.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Nikiforou, Dimitra
- Νικηφόρου, Δήμητρα
Subjects
dc:subject × 19- Βιομόρια
- Τ λεμφοκύτταρα
- Διπεπτίδυλο πεπτιδάση IV
- Δεαμινάση αδενοσίνης
- Ρευματοειδής αρθρίτιδα
- Συστηματικός ερυθηματώδης λύκος ( ΣΕΛ)
- Φωσφατάση τυροσίνης
- Biomolecules
- CD26, dipeptidyl peptidase IV
- Adenosine deaminase, ADA
- CD45RA
- CD45RO
- Rheumatoid arthritis
- Systemic lupus erythematosus ( SLE)
- T lymphocytes
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/33181